Breaking News Instant updates and real-time market news.

2021-12-14 06:18:00 ARNA Arena Pharmaceuticals $90.03 / +40.26 (+80.89%) , PFE Pfizer $55.23 / +2.43 (+4.60%) 06:18 12/14/21 12/14 06:18 12/14/21 06:18	Arena Pharmaceuticals downgraded to Market Perform at JMP Securities JMP Securities analyst Jason Butler downgraded Arena Pharmaceuticals (ARNA) to Market Perform from Outperform after Pfizer (PFE) announced an agreement to acquire Arena for $100 per share in cash in a transaction with a total equity value of approximately $6.7B. ARNA Arena Pharmaceuticals $90.03 / +40.26 (+80.89%) PFE Pfizer $55.23 / +2.43 (+4.60%)	17 Dec 29 Dec 06 Jan 23 Jan 24 Jan 06 May

2021-12-14 06:18:00

ARNA

Arena Pharmaceuticals

$90.03 / +40.26 (+80.89%)

, PFE

Pfizer

$55.23 / +2.43 (+4.60%)

06:18

12/14/21

12/14

06:18

12/14/21

06:18

Arena Pharmaceuticals downgraded to Market Perform at JMP Securities

JMP Securities analyst Jason Butler downgraded Arena Pharmaceuticals (ARNA) to Market Perform from Outperform after Pfizer (PFE) announced an agreement to acquire Arena for $100 per share in cash in a transaction with a total equity value of approximately $6.7B.

ARNA

Arena Pharmaceuticals

$90.03 / +40.26 (+80.89%)

PFE

Pfizer

$55.23 / +2.43 (+4.60%)

17
Dec
29
Dec
06
Jan
23
Jan
24
Jan
06
May

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 DVAX Dynavax $12.34 / +0.07 (+0.57%) China's Clover… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/17/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 05/12/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 02/28/22 Dynavax sees FY22 CpG 1018 adjuvant net product revenues of $550M 12/28/21 Dynavax notes Biological E's CORBEVAX received DCGI emergency use approval DVAX Dynavax $12.34 / +0.07 (+0.57%) 01/05/22 Goldman Sachs Goldman reinstates Dynavax at Buy, sees value creation from COVID platform 12/29/21 H.C. Wainwright Dynavax price target raised to $28 from $23 at H.C. Wainwright 08/31/21 H.C. Wainwright Dynavax price target raised to $23 from $20 at H.C. Wainwright 08/05/21 Goldman Sachs Dynavax initiated with a Buy at Goldman Sachs DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/05/22 Dynavax still sees 2022 CpG 1018 adjuvant revenues at least $550M 05/05/22 Dynavax reports Q1 EPS 26c, consensus 24c 02/28/22 Dynavax reports Q4 EPS 55c, consensus 64c DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/12/22 Fly Intel: After-Hours Movers
Hot Stocks	TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) TG Therapeutics … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/03/22 TG Therapeutics announces data presentations from ULTIMATE I, II Phase 3 trials 05/31/22 TG Therapeutics announces FDA extension of BLA PDUFA date for ublituximab 04/15/22 TG Therapeutics withdraws leukemia application, pulls Ukoniq from sale 04/06/22 TG Therapeutics announces presentation of ULTIMATE I & II Phase 3 trial data TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/13/22 B. Riley TG Therapeutics price target lowered to $17 from $23 at B. Riley 05/20/22 BofA BofA starts TG Therapeutics at Underperform, sees difficult commercial setup 05/20/22 BofA TG Therapeutics initiated with an Underperform at BofA 04/19/22 B. Riley TG Therapeutics application withdrawal 'clearing event,' says B. Riley TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 03/01/22 TG Therapeutics reports Q4 EPS (70c), consensus (63c) TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 04/18/22 What You Missed On Wall Street On Monday 04/18/22 What You Missed On Wall Street This Morning 01/27/22 Wall Street in Fives - Must Read Lists for Thursday 01/27/22 Wall Street in Fives - Must Read Lists at Midday TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/09/22 Unusually active option classes on open June 9th 04/29/22 TG Therapeutics call volume above normal and directionally bullish
Recommendations	Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TV Televisa $8.71 / +0.34 (+4.06%) JPMorgan analyst Marcelo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly TV Televisa $8.71 / +0.34 (+4.06%) 06/01/22 Goldman Sachs Televisa reinstated with a Neutral at Goldman Sachs 03/23/22 Barclays Televisa upgraded to Equal Weight from Underweight at Barclays 03/18/22 JPMorgan America Movil downgraded to Neutral from Overweight at JPMorgan 03/18/22 JPMorgan Televisa resumed with Overweight from Neutral at JPMorgan TV Televisa $8.71 / +0.34 (+4.06%) 03/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 CPA Copa Holdings $63.84 / +2.61 (+4.26%) JPMorgan analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CPA Copa Holdings $63.84 / +2.61 (+4.26%) 06/10/22 Copa Holdings reports preliminary May traffic down 4.2%, capacity down 3.7% 05/10/22 Copa Holdings reports preliminary April traffic statistics 04/13/22 Copa Holdings reports preliminary March traffic statistics 03/10/22 Copa Holdings reports preliminary February traffic down 13% vs. 2019 CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/13/22 Barclays Barclays double upgrades Copa Holdings on improving operations 05/13/22 Barclays Copa Holdings upgraded to Overweight from Underweight at Barclays 04/13/22 Raymond James Copa Holdings price target lowered to $110 from $115 at Raymond James 02/23/22 Barclays Copa Holdings price target raised to $96 from $82 at Barclays CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/11/22 Copa Holdings reports Q1 EPS 47c, consensus 29c 02/09/22 Copa Holdings reports Q4 EPS ex-items $1.98, consensus 89c
Hot Stocks	DocGo to be added to Russell 2000 Index » 07:37 06/27/22 06/27 07:37 06/27/22 07:37 DCGO DocGo $7.11 / -0.39 (-5.20%) DocGo announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DCGO DocGo $7.11 / -0.39 (-5.20%) 05/24/22 DocGo announces $40M share repurchase plan 05/17/22 DocGo expands mobile health services with Carnival 04/26/22 DocGo, Jefferson Health partner for patient transport 03/30/22 DocGo unit Ambulnz Community Partners awarded three 'sizeable' contracts DCGO DocGo $7.11 / -0.39 (-5.20%) 05/11/22 Canaccord DocGo price target lowered to $10 from $13 at Canaccord 04/19/22 Deutsche Bank DocGo initiated with a Buy at Deutsche Bank 01/19/22 Stifel DocGo initiated with a Buy at Stifel 01/04/22 Northland DocGo named a top pick for 2022 at Northland DCGO DocGo $7.11 / -0.39 (-5.20%) 05/09/22 DocGo backs FY22 revenue view $400M-$420M, consensus $410.59M 05/09/22 DocGo reports Q1 EPS 9c, consensus 4c 03/14/22 DocGo sees FY22 revenue $400M-$420M, consensus $385.2M 03/14/22 DocGo reports Q4 net income $20.3M vs. ($4.4M) last year DCGO DocGo $7.11 / -0.39 (-5.20%) 01/11/22 Nine new option listings on January 11th

Hot Stocks	BridgeBio announces data for for BBP-711 to treat recurrent kidney stone formers » 07:35 06/27/22 06/27 07:35 06/27/22 07:35 BBIO BridgeBio $9.24 / +0.175 (+1.93%) BridgeBio Pharma … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BBIO BridgeBio $9.24 / +0.175 (+1.93%) 06/22/22 BridgeBio announces early data for BBP-812 06/17/22 Atai Life Sciences says Stephen Bardin to be named CFO in Q3 06/13/22 BridgeBio shares data from Phase 2b trial of encaleret 06/10/22 BridgeBio affiliate Venthera presents preliminary results from VT30 trial BBIO BridgeBio $9.24 / +0.175 (+1.93%) 03/16/22 H.C. Wainwright BridgeBio price target lowered to $22 from $24 at H.C. Wainwright 03/11/22 JPMorgan BridgeBio price target lowered to $18 from $21 at JPMorgan 01/03/22 Piper Sandler Alnylam upgraded to Overweight from Neutral at Piper Sandler 12/30/21 BofA Alnylam remains top pick for 2022 at Bofa amid recent volatility BBIO BridgeBio $9.24 / +0.175 (+1.93%) 05/05/22 BridgeBio reports Q1 EPS ($1.35), consensus ($1.11) 02/24/22 BridgeBio reports Q4 EPS ($1.01), consensus (87c) BBIO BridgeBio $9.24 / +0.175 (+1.93%) 05/12/22 Fly Intel: Pre-market Movers 12/27/21 Wall Street in Fives - Must Read Lists for Monday 12/27/21 Wall Street in Fives - Must Read Lists at Midday 12/27/21 Fly Intel: Pre-market Movers BBIO BridgeBio $9.24 / +0.175 (+1.93%) 01/03/22 Unusually active option classes on open January 3rd 12/28/21 Unusually active option classes on open December 28th
Downgrade	Morgan Stanley downgrades Varonis to Equal Weight on slowing topline growth » 07:35 06/27/22 06/27 07:35 06/27/22 07:35 VRNS Varonis $34.92 / +2.04 (+6.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VRNS Varonis $34.92 / +2.04 (+6.20%) 06/15/22 Varonis announces new features for cloud security offering 05/25/22 Varonis achieves Cloud Security Alliance STAR Certfication 04/26/22 Varonis announces features for securing sensitive data in Salesforce 01/25/22 Varonis announces Version 8.6 of the Varonis Data Security Platform VRNS Varonis $34.92 / +2.04 (+6.20%) 05:34 Today Morgan Stanley Varonis downgraded to Equal Weight from Overweight at Morgan Stanley 05/23/22 Jefferies Varonis price target lowered to $40 from $65 at Jefferies 05/10/22 Truist Varonis price target lowered to $50 from $65 at Truist 05/03/22 Wedbush Varonis price target lowered to $52 from $60 at Wedbush VRNS Varonis $34.92 / +2.04 (+6.20%) 05/02/22 Notable companies reporting after market close 02/07/22 Varonis sees FY22 EPS 16c-17c, consensus 22c 02/07/22 Varonis sees Q1 EPS (11c)-(10c), consensus (6c) 02/07/22 Varonis reports Q4 EPS 16c, consensus 13c VRNS Varonis $34.92 / +2.04 (+6.20%) 05/02/22 Fly Intel: After-Hours Movers 04/26/22 What Wall Street is saying about Alphabet ahead of earnings
Earnings	Stealth Biotherapeutics announces receipt of preliminary non-binding proposal » 07:34 06/27/22 06/27 07:34 06/27/22 07:34 MITO Stealth Biotherapeutics / + Stealth BioTherapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research MITO Stealth Biotherapeutics / + 07:28 Today Stealth BioTherapeutics Corporation (ADS) trading halted, news pending 06/14/22 Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide 06/08/22 Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study 05/31/22 Stealth granted orphan drug designation for elamipretide by EMA MITO Stealth Biotherapeutics / + 05/23/22 H.C. Wainwright Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks	Foot Locker to divest team sales business » 07:33 06/27/22 06/27 07:33 06/27/22 07:33 FL Foot Locker $29.56 / +0.53 (+1.83%) Foot Locker announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $29.56 / +0.53 (+1.83%) 07:32 Today Foot Locker to divest team sales business 06/01/22 Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% FL Foot Locker $29.56 / +0.53 (+1.83%) 05/24/22 Williams Trading Foot Locker downgraded to Sell from Hold at Williams Trading 05/23/22 B. Riley Foot Locker price target lowered to $33 from $34 at B. Riley 05/23/22 Deutsche Bank Foot Locker price target raised to $32 from $30 at Deutsche Bank 05/23/22 Baird Foot Locker price target raised to $32 from $30 FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $29.56 / +0.53 (+1.83%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 08/19/22 Foot Locker - FL FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd
Hot Stocks	Holley added to membership of the small-cap Russell 2000 Index » 07:33 06/27/22 06/27 07:33 06/27/22 07:33 HLLY Holley $10.21 / +0.21 (+2.10%) Holley was added as a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly HLLY Holley $10.21 / +0.21 (+2.10%) 04/20/22 Holley falls -9.9% 04/20/22 Holley falls -9.2% 04/20/22 Holley falls -8.0% 01/10/22 Holley completes acquisition of brands during Q4 for approximately $56M HLLY Holley $10.21 / +0.21 (+2.10%) 06/22/22 BofA Holley initiated with a Buy at BofA 03/04/22 Jefferies Holley assumed with a Buy rating, $20 price target at Jefferies 09/09/21 Truist Truist starts Holley at Buy with positive view of secular growth attributes 09/09/21 Truist Holley initiated with a Buy at Truist HLLY Holley $10.21 / +0.21 (+2.10%) 05/12/22 Holley reports Q1 EPS 18c, consensus 15c 04/19/22 Holley sees Q1 revenue $199M-$200M, consensus $180.6M 03/03/22 Holley sees FY22 revenue $765-$790M, consensus $718.69M 03/03/22 Holley reports Q4 EPS 8c consensus 12c 21 Apr HLLY Holley $10.21 / +0.21 (+2.10%) 06/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/19/22 Fly Intel: After-Hours Movers 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Hot Stocks	Digital World Acquisition says Garelick to resign from board » 07:32 06/27/22 06/27 07:32 06/27/22 07:32 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 07:31 Today Trump-linked SPAC Digital World reports receipt of grand jury subpoena 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena 05/18/22 Trump Media & Technology Group launches Truth Social Web App DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Hot Stocks	Foot Locker to divest team sales business 07:32 06/27/22 06/27 07:32 06/27/22 07:32 FL Foot Locker $29.56 / +0.53 (+1.83%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $29.56 / +0.53 (+1.83%) 06/01/22 Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% 05/05/22 Foot Locker, Adidas announce new long-term strategic partnership FL Foot Locker $29.56 / +0.53 (+1.83%) 05/24/22 Williams Trading Foot Locker downgraded to Sell from Hold at Williams Trading 05/23/22 B. Riley Foot Locker price target lowered to $33 from $34 at B. Riley 05/23/22 Deutsche Bank Foot Locker price target raised to $32 from $30 at Deutsche Bank 05/23/22 Baird Foot Locker price target raised to $32 from $30 FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $29.56 / +0.53 (+1.83%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 08/19/22 Foot Locker - FL FL Foot Locker $29.56 / +0.53 (+1.83%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd
Hot Stocks	Aptose Biosciences appoints Fletcher Payne as SVP, CFO » 07:32 06/27/22 06/27 07:32 06/27/22 07:32 APTO Aptose Biosciences / + Aptose Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings APTO Aptose Biosciences / + 06/02/22 Aptose Biosciences presents highlights from corporate update, KOL event 05/04/22 Aptose Biosciences receives Fast Track designation for HM43239 04/13/22 iKena Oncology appoints Marango as CFO, Head of Corporate Development 04/07/22 Aptose Biosciences appoints Ledru as CCO, Marango to resign as CFO, CBO APTO Aptose Biosciences / + 04/28/22 Cantor Fitzgerald Aptose Biosciences assumed with an Overweight at Cantor Fitzgerald 12/20/21 Piper Sandler Aptose Biosciences price target lowered to $3 from $7 at Piper Sandler 12/20/21 H.C. Wainwright Aptose price target lowered to $12 from $14 at H.C. Wainwright 12/14/21 Alliance Global Partners Aptose price target lowered to $8 from $12 at Alliance Global Partners APTO Aptose Biosciences / + 05/09/22 Aptose Biosciences reports Q1 EPS (12c), consensus (15c)
Hot Stocks	Trump-linked SPAC Digital World reports receipt of grand jury subpoena » 07:31 06/27/22 06/27 07:31 06/27/22 07:31 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena 05/18/22 Trump Media & Technology Group launches Truth Social Web App 05/16/22 Trump 'generally obligated' to give TruthSocial six hour head start DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Hot Stocks	nCino names Chris Ainsworth as chief people officer » 07:31 06/27/22 06/27 07:31 06/27/22 07:31 NCNO nCino $37.19 / +2.54 (+7.33%) nCino announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NCNO nCino $37.19 / +2.54 (+7.33%) 06/14/22 SimpleNexus announces Family First Funding has implemented Nexus Engagement 05/25/22 nCino announces AnnieMac completed rollout of Nexus Engagement, Origination 04/28/22 nCino selected by connectFirst to deploy its Banking Operating System 04/05/22 nCino's SimpleNexus announces Pinnacle Bank implemented Nexus Vision NCNO nCino $37.19 / +2.54 (+7.33%) 06/02/22 Truist nCino price target lowered to $70 from $80 at Truist 06/02/22 Needham nCino price target lowered to $42 from $60 at Needham 06/02/22 Barclays nCino price target raised to $39 from $38 at Barclays 06/02/22 KeyBanc nCino price target lowered to $45 from $60 at KeyBanc NCNO nCino $37.19 / +2.54 (+7.33%) 06/01/22 nCino sees FY23 EPS (30c)-(28c), consensus (32c) 06/01/22 nCino sees Q2 EPS (8c)-(9c), consensus (8c) 06/01/22 nCino reports Q1 EPS (6c), consensus (8c) 03/31/22 nCino reports Q4 EPS (9c), consensus (9c) NCNO nCino $37.19 / +2.54 (+7.33%) 04/04/22 nCino rumor mentioned in 'uncooked alert' by Betaville NCNO nCino $37.19 / +2.54 (+7.33%) 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/10/22 Fly Intel: After-Hours Movers NCNO nCino $37.19 / +2.54 (+7.33%) 06/01/22 nCino options imply 8.1% move in share price post-earnings 03/31/22 nCino options imply 10.8% move in share price post-earnings

Hot Stocks	Stealth BioTherapeutics Corporation (ADS) trading halted, news pending 07:28 06/27/22 06/27 07:28 06/27/22 07:28 MITO Stealth Biotherapeutics / + ShowHide Related Items >><< Company News Street Research MITO Stealth Biotherapeutics / + 06/14/22 Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide 06/08/22 Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study 05/31/22 Stealth granted orphan drug designation for elamipretide by EMA 05/23/22 Stealth Biotherapeutics reports Phase 2 results of elamipretide in GA MITO Stealth Biotherapeutics / + 05/23/22 H.C. Wainwright Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks	Parsons to help modernize, expand Asheville regional airport » 07:27 06/27/22 06/27 07:27 06/27/22 07:27 PSN Parsons $40.43 / +2.1 (+5.48%) Parsons Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN Parsons $40.43 / +2.1 (+5.48%) 06/21/22 Parsons appoints Tim Schmitt to executive leadership team 06/16/22 Parsons selected by DHA on $10B Omnibus IV contract 06/01/22 Parsons completes acquisition of Xator Corporation 05/26/22 Parsons awarded contract for AI-based smart mobility system PSN Parsons $40.43 / +2.1 (+5.48%) 04/22/22 Truist Parsons downgraded to Hold from Buy at Truist 03/17/22 Stifel Parsons resumed with a Buy at Stifel 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA PSN Parsons $40.43 / +2.1 (+5.48%) 05/04/22 Parsons backs 2022 revenue view $3.7B-$3.9B, consensus $3.8B 05/04/22 Parsons reports Q1 adjusted EPS 40c, consensus 38c 02/23/22 Parsons sees 2022 revenue $3.7B-$3.9B, consensus $3.79B 02/23/22 Parsons reports Q4 adjusted EPS 55c, consensus 53c PSN Parsons $40.43 / +2.1 (+5.48%) 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/08/22 7th Annual Wells Fargo FinTech & Technology Services Forum
Recommendations	Blucora 'a most interesting,' under-the-radar idea, says Benchmark » 07:23 06/27/22 06/27 07:23 06/27/22 07:23 BCOR Blucora $18.43 / +0.72 (+4.07%) After having recently… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BCOR Blucora $18.43 / +0.72 (+4.07%) 06/06/22 Avantax welcomes ATS Advanced Trustee Strategies 03/15/22 Engine Capital withdraws nomination of candidates for election to Blucora 02/17/22 Avantax acquires Gene Bell & Associates, terms not disclosed 02/14/22 Blucora issues statement in response to Engine Capital director nominations BCOR Blucora $18.43 / +0.72 (+4.07%) 05/04/22 Barrington Blucora weakness a buying opportunity, says Barrington 12/14/21 JPMorgan Blucora downgraded to Neutral from Overweight at JPMorgan 12/14/21 JPMorgan Blucora downgraded to Neutral from Overweight at JPMorgan 11/05/21 Barrington Blucora price target raised to $23 from $21 at Barrington BCOR Blucora $18.43 / +0.72 (+4.07%) 02/16/22 Blucora sees Q1 adjusted EPS $1.04-$1.52 , consensus $1.46 02/16/22 Blucora reports Q4 adjusted EPS (29c), consensus (45c)
Recommendations	CMS Energy price target lowered to $71 from $80 at BMO Capital » 07:22 06/27/22 06/27 07:22 06/27/22 07:22 CMS CMS Energy $65.16 / +1.03 (+1.61%) BMO Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMS CMS Energy $65.16 / +1.03 (+1.61%) 05/18/22 CMS Energy to add 300 megawatts of clean energy from two Michigan solar projects 05/09/22 Consumers Energy looks to work with landowners to identify power plant sites 04/20/22 CMS Energy, key stakeholders reach settlement agreement on Clean Energy Plan 02/01/22 Consumers Energy, General Motors announce clean energy pledge CMS CMS Energy $65.16 / +1.03 (+1.61%) 04/25/22 Credit Suisse CMS Energy initiated with a Neutral at Credit Suisse 04/21/22 Mizuho CMS Energy price target raised to $77 from $70 at Mizuho 04/19/22 Barclays CMS Energy downgraded to Equal Weight from Overweight at Barclays 04/07/22 KeyBanc CMS Energy downgraded to Sector Weight from Overweight at KeyBanc CMS CMS Energy $65.16 / +1.03 (+1.61%) 05/03/22 CMS Energy reaffirms FY22 adjusted EPS view $2.85-$2.89, consensus $2.87 05/03/22 CMS Energy reports Q1 EPS $1.21, consensus $1.12 02/03/22 CMS Energy raises 2022 adj EPS view to $2.85-$2.89 from $2.85-$2.87 02/03/22 CMS Energy reports Q4 cont-op EPS 40c, consensus 44c
Recommendations	DoorDash price target lowered to $100 from $140 at Needham » 07:19 06/27/22 06/27 07:19 06/27/22 07:19 DASH DoorDash $74.15 / +3.84 (+5.46%) Needham analyst Bernie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options DASH DoorDash $74.15 / +3.84 (+5.46%) 06/13/22 DoorDash launches new app features to 'rate, review and discover' 06/08/22 Uber debuts Nationwide shipping, enables 'cross-country cravings' from US cities 05/20/22 DoorDash discloses $400M share repurchase program 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe DASH DoorDash $74.15 / +3.84 (+5.46%) 06/21/22 Goldman Sachs DoorDash reinstated with a Neutral at Goldman Sachs 06/06/22 Raymond James DoorDash initiated with a Market Perform at Raymond James 06/03/22 DA Davidson DoorDash price target lowered to $82 from $135 at DA Davidson 06/02/22 JMP Securities DoorDash price target lowered to $150 from $200 at JMP Securities DASH DoorDash $74.15 / +3.84 (+5.46%) 05/05/22 DoorDash reports Q1 EPS (48c), consensus (41c) 05/05/22 Notable companies reporting after market close 02/16/22 DoorDash reports Q4 EPS (45c), consensus (25c) 02/16/22 Notable companies reporting after market close 19 Aug DASH DoorDash $74.15 / +3.84 (+5.46%) 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 03/23/22 Instacart plans to launch 15-minute grocery delivery service, Information says 03/17/22 Ride-hailing, delivery app drivers stretched amid spiking gas prices, NYT says 03/08/22 Uber, Lyft, others launch ad campaign to prevent unions, WSJ reports DASH DoorDash $74.15 / +3.84 (+5.46%) 06/25/22 Opening Day: Golden Sun rises in debut as Ivanhoe Electric delays IPO 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/11/22 Opening Day: EV-focused Phoenix Motor drops in market debut 06/06/22 What You Missed On Wall Street On Monday DASH DoorDash $74.15 / +3.84 (+5.46%) 06/01/22 DoorDash put volume heavy and directionally bearish 05/05/22 DoorDash options imply 13.1% move in share price post-earnings 05/05/22 Unusually active option classes on open May 5th 04/26/22 DoorDash put volume heavy and directionally bearish

Hot Stocks	Agrify enters New Zealand cannabis market with $1.625M Ora Pharm pact » 07:19 06/27/22 06/27 07:19 06/27/22 07:19 AGFY Agrify $2.22 / +0.12 (+5.71%) Agrify announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AGFY Agrify $2.22 / +0.12 (+5.71%) 06/01/22 Agrify announces launch of CannaBeast 13 short path 05/25/22 Agrify reminds stockholders to vote before proxy voting deadline 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs 05/10/22 Agrify announces multimillion dollar engagement with Boone Labs AGFY Agrify $2.22 / +0.12 (+5.71%) 05/12/22 Alliance Global Partners Agrify price target lowered to $11 from $15 at Alliance Global Partners 03/25/22 Alliance Global Partners Agrify price target lowered to $15 from $32 at Alliance Global Partners 03/24/22 Maxim Agrify price target lowered to $12 from $40 at Maxim 03/23/22 Craig-Hallum Agrify downgraded to Hold at Craig-Hallum on covenant tripping risk AGFY Agrify $2.22 / +0.12 (+5.71%) 05/11/22 Agrify reports Q1 EPS (36c), consensus (33c) 03/23/22 Agrify sees FY22 revenue $140M-$142M, consensus $144.28M 03/23/22 Agrify reports Q4 EPS (60c), consensus (31c) 01/20/22 Agrify reaffirms Q4 revenue guidance of $26M-$28M, consensus $27.84M AGFY Agrify $2.22 / +0.12 (+5.71%) 03/23/22 Fly Intel: Pre-market Movers
Recommendations	Okta not seeing backlash from security breach, says William Blair » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 OKTA Okta $101.20 / +7.8099 (+8.36%) , MSFT Microsoft $267.85 / +8.84 (+3.41%) William Blair analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta jumps 16% to $108.35 after raising fiscal year outlook 04/20/22 Okta says January breach lasted 25 minutes, impacted two customers 03/25/22 Okta does not consider January cyber incident 'to be material' 03/22/22 Microsoft says Lapsus$ stole source code through 'limited' access MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Ralph Lauren announces nomination of Cupp to board of directors 06/16/22 Square Enix says 'Final Fantasy 7 Rebirth' out next winter for PS5 06/16/22 Microsoft introduces Microsoft Defender for individuals 06/15/22 AvePoint adds Microsoft Azure backup to enhance data protection capabilities OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 Morgan Stanley Okta Q1 report should be 'clearing event,' says Morgan Stanley 06/03/22 DA Davidson Okta price target raised to $140 from $125 at DA Davidson 06/03/22 Oppenheimer Okta price target lowered to $170 from $210 at Oppenheimer 06/03/22 BTIG Okta price target lowered to $152 from $216 at BTIG MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/24/22 Citi Citi names top software picks with sector de-rating 'mostly done' 06/17/22 Morgan Stanley Microsoft gaming build out hitting 'overdrive,' says Morgan Stanley 06/16/22 Credit Suisse Credit Suisse says Microsoft Azure growth opportunity not reflected in estimates 06/13/22 Jefferies Microsoft price target lowered to $320 from $325 at Jefferies OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta raises FY23 adjusted EPS view to ($1.14)-($1.11), consensus ($1.25) 06/02/22 Okta sees Q2 adjusted EPS (32c)-(31c), consensus (33c) 06/02/22 Okta reports Q1 adjusted EPS (27c), consensus (34c) 06/02/22 Notable companies reporting after market close MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 04/26/22 Notable companies reporting after market close OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 03/29/22 Okta slow to respond to Lapsus$ Hack, leaked details show, Wired reports 01/01/22 Amazon looks particularly attractive after wild year for tech, Barron's says MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/23/22 Blizzard's 'Overwatch 2' to replace original 'Overwatch' live service, IGN says 06/23/22 Walmart reducing dependence on cloud giants with new capabilities, WSJ reports 06/22/22 Microsoft plans to do more to slow Russian propaganda, WaPo reports 06/21/22 Activision holders approve public harassment reporting proposal, WaPo says OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/03/22 What You Missed On Wall Street On Friday 06/03/22 What You Missed On Wall Street This Morning 06/03/22 Fly Intel: Pre-market Movers 06/02/22 Fly Intel: After-Hours Movers MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/22/22 What You Missed This Week in Video Games 06/22/22 What You Missed On Wall Street This Morning 06/14/22 What You Missed This Week in Video Games 06/10/22 What You Missed On Wall Street This Morning OKTA MSFT OKTA Okta $101.20 / +7.8099 (+8.36%) 06/02/22 Okta options imply 8.8% move in share price post-earnings 03/22/22 Unusually active option classes on open March 22nd 02/18/22 Okta put volume heavy and directionally bearish 01/21/22 Okta put volume heavy and directionally bearish MSFT Microsoft $267.85 / +8.84 (+3.41%) 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd 05/31/22 Microsoft call volume above normal and directionally bullish 05/02/22 Microsoft put buyer realizes 57% same-day gains
Hot Stocks	Capricor Therapeutics announces one-year results from HOPE-2 OLE study » 07:18 06/27/22 06/27 07:18 06/27/22 07:18 CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) Capricor Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 05/25/22 Capricor Therapeutics appoints Avat as Chief Business Officer 03/28/22 Capricor Therapeutics reports results from Phase 2 INSPIRE study 03/11/22 Capricor Therapeutics publishes results from Phase 2 study of CAP-1002 03/02/22 Capricor Therapeutics appoints Paulson as VP of Clinical Development CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 01/31/22 H.C. Wainwright Capricor Therapeutics price target raised to $18 from $14 at H.C. Wainwright 10/11/21 H.C. Wainwright Capricor Therapeutics price target raised to $14 from $9 at H.C. Wainwright CAPR Capricor Therapeutics $4.52 / -0.03 (-0.66%) 03/10/22 Capricor Therapeutics options imply 18.1% move in share price post-earnings
Recommendations	CarMax price target raised to $105 from $90 at Wedbush » 07:16 06/27/22 06/27 07:16 06/27/22 07:16 KMX CarMax $98.44 / +6.68 (+7.28%) Wedbush analyst Seth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax plans to open ten new locations in FY23 06/24/22 CarMax sold 427,257 units in Q1, down 5.5% from the prior year quarter 05/16/22 Tepper's Appaloosa buys two casinos in Q1, exits T-Mobile and GM 04/12/22 CarMax drops 5% to $98.05 after Q4 earnings miss estimates KMX CarMax $98.44 / +6.68 (+7.28%) 06:54 Today Baird CarMax valuation attractive for patient investors, says Baird 06/07/22 JPMorgan CarMax price target lowered to $105 from $110 at JPMorgan 05/16/22 Evercore ISI CarMax added to 'Tactical Outperform' list at Evercore ISI 05/02/22 Needham Needham starts CarMax at Hold amid increased spending on omni-channel strategy KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 CarMax reports Q1 EPS $1.56, consensus $1.49 06/23/22 Notable companies reporting before tomorrow's open 06/23/22 Notable companies reporting before tomorrow's open 04/12/22 CarMax reports Q4 EPS 98c, consensus $1.25 KMX CarMax $98.44 / +6.68 (+7.28%) 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says KMX CarMax $98.44 / +6.68 (+7.28%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/13/22 What You Missed On Wall Street On Wednesday 09/29/22 CarMax - KMX 06/28/22 CarMax Inc. KMX CarMax $98.44 / +6.68 (+7.28%) 04/12/22 Unusually active option classes on open April 12th
Hot Stocks	Frontier Group issues open letter to Spirit Airlines shareholders » 07:15 06/27/22 06/27 07:15 06/27/22 07:15 ULCC Frontier Group $10.53 / +0.655 (+6.64%) , SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) Frontier Group (ULCC),… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/26/22 Fly Intel: Top five weekend stock stories 06/26/22 ISS recommends Spirit holders vote for amended merger agreement with Frontier 06/24/22 Spirit Airlines board says JetBlue's revised offer 'not a Superior Proposal' 06/24/22 Frontier Group raises Spirit Airlines deal consideration by $2.00 per share ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation 04/06/22 MKM Partners MKM Partners expects to see 'heavy regulatory pushback' to JetBlue-Spirit deal SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Raymond James Frontier Group upgraded to Outperform from Market Perform at Raymond James 06/10/22 JPMorgan Spirit Airlines upgraded to Overweight from Neutral at JPMorgan 05/05/22 Deutsche Bank Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank 04/11/22 MKM Partners JetBlue upgraded to Neutral at MKM Partners on valuation ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/28/22 Frontier Group sees Q2 pre-tax margin between 1%-5% 04/28/22 Frontier Group reports Q1 EPS (56c), consensus (43c) 02/07/22 Frontier Group is not providing guidance 02/07/22 Frontier Group is not providing guidance SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/20/22 Fly Intel: Top five weekend stock stories 05/04/22 Spirit Airlines sees FY22 other capital expenditures $240M 05/04/22 Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B 05/04/22 Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58) ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 04/05/22 JetBlue offers roughly $3.6B for Spirit Airlines, NY Times says SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/17/22 Buttigieg asks airlines to prepare for potentially busy summer, WSJ reports 06/10/22 CDC to lift negative test requirement to enter U.S., CNN reports 04/21/22 DOJ appeals transportation mask mandate ruling, NYT reports 04/20/22 CDC requests that DOJ appeal ruling to lift travel mask mandate, CNBC says ULCC SAVE ULCC Frontier Group $10.53 / +0.655 (+6.64%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/30/22 Spirit Airlines, Inc. SAVE SAVE Spirit Airlines $24.54 / +0.71 (+2.98%) 06/24/22 Spirit Airlines call volume above normal and directionally bullish 05/16/22 Unusually active option classes on open May 16th 05/12/22 Spirit Airlines call volume above normal and directionally bullish 04/06/22 Unusually active option classes on open April 6th

Events

Earnings calls, analyst events, roadshows and more

RLAY
Today at 08:00

Relay Therapeutics Firm Sponsored Meetings

Virtual Meeting
THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Arena Pharmaceuticals downgraded to Market Perform at JMP Securities

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access